417 related articles for article (PubMed ID: 22280355)
1. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
Zhang G; Wang Y; Zhang Y; Wan X; Li J; Liu K; Wang F; Liu K; Liu Q; Yang C; Yu P; Huang Y; Wang S; Jiang P; Qu Z; Luan J; Duan H; Zhang L; Hou A; Jin S; Hsieh TC; Wu E
Curr Mol Med; 2012 Feb; 12(2):163-76. PubMed ID: 22280355
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
Thangapazham RL; Passi N; Maheshwari RK
Cancer Biol Ther; 2007 Dec; 6(12):1938-43. PubMed ID: 18059161
[TBL] [Abstract][Full Text] [Related]
3. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
[TBL] [Abstract][Full Text] [Related]
4. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met.
Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH
J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466
[TBL] [Abstract][Full Text] [Related]
5. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9.
Luo KW; Wei Chen ; Lung WY; Wei XY; Cheng BH; Cai ZM; Huang WR
J Nutr Biochem; 2017 Mar; 41():56-64. PubMed ID: 28040581
[TBL] [Abstract][Full Text] [Related]
6. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Farabegoli F; Govoni M; Spisni E; Papi A
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
[TBL] [Abstract][Full Text] [Related]
7. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Bigelow RL; Cardelli JA
Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
9. Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling.
Cui H; Yuan J; Du X; Wang M; Yue L; Liu J
Oncol Rep; 2015 Mar; 33(3):1284-90. PubMed ID: 25522911
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
Sen T; Chatterjee A
Eur J Nutr; 2011 Sep; 50(6):465-78. PubMed ID: 21170718
[TBL] [Abstract][Full Text] [Related]
11. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
Ahmad N; Gupta S; Mukhtar H
Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
Park SB; Bae JW; Kim JM; Lee SG; Han M
Int J Mol Med; 2012 Nov; 30(5):1211-8. PubMed ID: 22923012
[TBL] [Abstract][Full Text] [Related]
13. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
14. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
Syed DN; Afaq F; Kweon MH; Hadi N; Bhatia N; Spiegelman VS; Mukhtar H
Oncogene; 2007 Feb; 26(5):673-82. PubMed ID: 16862172
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
Mineva ND; Paulson KE; Naber SP; Yee AS; Sonenshein GE
PLoS One; 2013; 8(9):e73464. PubMed ID: 24039951
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
19. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]